UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Could there be Haemodynamic Stress Effects on Pro-Inflammatory CD14+CD16+ Monocytes during Convective-Diffusive Treatments? A Prospective Randomized Controlled Trial

Blood purification, 2019-01, Vol.47 (4), p.385-394

2019

Volltextzugriff (PDF)

Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting

International journal of hematology, 2020-05, Vol.111 (5), p.614-618

2020

Volltextzugriff (PDF)

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Annals of hematology, 2020-07, Vol.99 (7), p.1675-1676

2020

Volltextzugriff (PDF)

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity

International journal of hematology, 2020-08, Vol.112 (2), p.141-146

2020

Volltextzugriff (PDF)

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis

Annals of hematology, 2022-04, Vol.101 (4), p.929-931

2022

Volltextzugriff (PDF)

Perls Stain Grade in Bone Marrow Aspirate Correlates with Overall Survival in Low-Risk Myelodysplastic Patients

Acta haematologica, 2021-05, Vol.144 (3), p.332-336

2021

Volltextzugriff (PDF)

Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia

Annals of hematology, 2022, Vol.101 (1), p.227-228

2022

Volltextzugriff (PDF)

Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy

Annals of hematology, 2022-04, Vol.101 (4), p.749-754

2022

Volltextzugriff (PDF)

Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

Acta haematologica, 2018-01, Vol.139 (3), p.164-165

2018

Volltextzugriff (PDF)

Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life

Acta haematologica, 2021-05, Vol.144 (3), p.322-326

2021

Volltextzugriff (PDF)

Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial

Hematological oncology, 2023-08, Vol.41 (3), p.415-423

2023

Volltextzugriff (PDF)

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

Annals of hematology, 2021-05, Vol.100 (5), p.1213-1219

2021

Volltextzugriff (PDF)

Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia

Annals of hematology, 2020-02, Vol.99 (2), p.363-365

2020

Volltextzugriff (PDF)

Long-term follow-up more than 10 years after HSCT: a monocentric experience

Journal of neurology, 2018-02, Vol.265 (2), p.410-416

2018

Volltextzugriff (PDF)

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine—Results from the Italian 'Back to Life' project

Quality of life research, 2018-06, Vol.27 (6), p.1545-1554

2018

Volltextzugriff (PDF)

Rectal involvement in pre-early T acute lymphoblastic leukemia

Annals of hematology, 2020-05, Vol.99 (5), p.1151-1152

2020

Volltextzugriff (PDF)

The Yin and Yang of myelodysplastic syndromes and autoimmunity: The paradox of autoimmune disorders responding to therapies specific for MDS

Critical reviews in oncology/hematology, 2019-10, Vol.142, p.51-57

2019

Volltextzugriff (PDF)

Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications

Leukemia research, 2022-06, Vol.117, p.106856-106856, Article 106856

2022

Volltextzugriff (PDF)

Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis

Annals of hematology, 2024-05, Vol.103 (5), p.1655-1664

2024

Volltextzugriff (PDF)

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Annals of hematology, 2020-05, p.1

2020

Volltextzugriff (PDF)

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura

Annals of hematology, 2024-07, Vol.103 (7), p.2523-2531

2024

Volltextzugriff (PDF)

Response to Dr. Ying Cui comments

Annals of hematology, 2024-09, Vol.103 (9), p.3829-3829

2024

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(69)
Berichte
(6)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Hematology
(50)
Humans
(49)
Oncology
(37)
Male
(32)
Female
(28)
Adult
(24)
Middle Aged
(23)
Aged
(22)
Medicine
(20)
Medicine & Public Health
(20)
Aged, 80 And Over
(16)
Treatment Outcome
(13)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(12)
Chronic Myeloid Leukemia
(10)
Leukemia
(10)
Original Article
(9)
Young Adult
(9)
Adolescent
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Could there be Haemodynamic Stress Effects on Pro-Inflammatory CD14+CD16+ Monocytes during Convective-Diffusive Treatments? A Prospective Randomized Controlled Trial

Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis

Perls Stain Grade in Bone Marrow Aspirate Correlates with Overall Survival in Low-Risk Myelodysplastic Patients

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia

Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy

Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life

Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia

Long-term follow-up more than 10 years after HSCT: a monocentric experience

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine—Results from the Italian 'Back to Life' project

Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice

Rectal involvement in pre-early T acute lymphoblastic leukemia

Favorable outcome of chronic myeloid leukemia co‐expressing e13a2 and e14a2 transcripts, treated with nilotinib

The Yin and Yang of myelodysplastic syndromes and autoimmunity: The paradox of autoimmune disorders responding to therapies specific for MDS

Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications

Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura

Response to Dr. Ying Cui comments

Aktive Filter

Suchergebnisse filtern